ID   7BD-33-11A
AC   CVCL_LC13
DR   Wikidata; Q54604990
RX   Patent=US7175846;
RX   Patent=US7431923;
RX   Patent=US7488475;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4890.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P08962; Human CD63.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
RX   Patent=US7175846;
RA   Young D.S.F., Hahn S.E., Findlay H.P.;
RT   "Cancerous disease modifying antibodies.";
RL   Patent number US7175846, 13-Feb-2007.
//
RX   Patent=US7431923;
RA   Young D.S.F., Hahn S.E., Findlay H.P., da Cruz L.A.G.;
RT   "Cytotoxicity mediation of cells evidencing surface expression of
RT   CD63.";
RL   Patent number US7431923, 07-Oct-2008.
//
RX   Patent=US7488475;
RA   Young D.S.F., Hahn S.E., Findlay H.P.;
RT   "Antibody therapy of tumors.";
RL   Patent number US7488475, 10-Feb-2009.
//